Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT04528251
Eligibility Criteria:
Inclusion Criteria:
* Having received azithromycin-ampicillin or sulbactam-ampicillin treatment during antenatal period with the diagnosis of preterm rupture of membranes that started before 34 weeks.
Exclusion Criteria:
* Having a disease detected in the perinatal or neonatal period (such as hydrops, congenital anomalies)
* Having a history of iatrogenic preterm birth
* Lethal or chromosomal anomaly
* Being diagnosed with perinatal hypoxia, hypoxic ischemic encephalopathy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Minute
Maximum Age:
15 Minutes
Study:
NCT04528251
Study Brief:
Protocol Section:
NCT04528251